These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18552452)

  • 1. Relationships among ET-1, PPARgamma, oxidative stress and endothelial dysfunction in diabetic animals.
    Matsumoto T; Kobayashi T; Kamata K
    J Smooth Muscle Res; 2008 Apr; 44(2):41-55. PubMed ID: 18552452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial PPARγ Is Crucial for Averting Age-Related Vascular Dysfunction by Stalling Oxidative Stress and ROCK.
    Uddin MS; Kabir MT; Jakaria M; Mamun AA; Niaz K; Amran MS; Barreto GE; Ashraf GM
    Neurotox Res; 2019 Oct; 36(3):583-601. PubMed ID: 31055770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor-gamma-mediated effects in the vasculature.
    Duan SZ; Usher MG; Mortensen RM
    Circ Res; 2008 Feb; 102(3):283-94. PubMed ID: 18276926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelium-specific interference with peroxisome proliferator activated receptor gamma causes cerebral vascular dysfunction in response to a high-fat diet.
    Beyer AM; de Lange WJ; Halabi CM; Modrick ML; Keen HL; Faraci FM; Sigmund CD
    Circ Res; 2008 Sep; 103(6):654-61. PubMed ID: 18676352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial PPARγ (Peroxisome Proliferator-Activated Receptor-γ) Is Essential for Preventing Endothelial Dysfunction With Aging.
    De Silva TM; Li Y; Kinzenbaw DA; Sigmund CD; Faraci FM
    Hypertension; 2018 Jul; 72(1):227-234. PubMed ID: 29735632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor-γ protects against vascular aging.
    Modrick ML; Kinzenbaw DA; Chu Y; Sigmund CD; Faraci FM
    Am J Physiol Regul Integr Comp Physiol; 2012 May; 302(10):R1184-90. PubMed ID: 22461176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The PI3-K/Akt pathway: roles related to alterations in vasomotor responses in diabetic models.
    Kobayashi T; Matsumoto T; Kamata K
    J Smooth Muscle Res; 2005 Dec; 41(6):283-302. PubMed ID: 16557003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosiglitazone via PPARγ-dependent suppression of oxidative stress attenuates endothelial dysfunction in rats fed homocysteine thiolactone.
    Yang XH; Li P; Yin YL; Tu JH; Dai W; Liu LY; Wang SX
    J Cell Mol Med; 2015 Apr; 19(4):826-35. PubMed ID: 25656735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular effects of PPARgamma activators - from bench to bedside.
    Marx N; Walcher D
    Prog Lipid Res; 2007 Nov; 46(6):283-96. PubMed ID: 17637478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Possible involvement of insulin and oxidative stress in vascular dysfunction of diabetic mellitus].
    Kobayashi T
    Yakugaku Zasshi; 2008 Jul; 128(7):1013-21. PubMed ID: 18591869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor (PPAR) gamma in cardiovascular disorders and cardiovascular surgery.
    Ivanova EA; Parolari A; Myasoedova V; Melnichenko AA; Bobryshev YV; Orekhov AN
    J Cardiol; 2015 Oct; 66(4):271-8. PubMed ID: 26072262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological activation of PPAR gamma ameliorates vascular endothelial insulin resistance via a non-canonical PPAR gamma-dependent nuclear factor-kappa B trans-repression pathway.
    Zhang Y; Zhan RX; Chen JQ; Gao Y; Chen L; Kong Y; Zhong XJ; Liu MQ; Chu JJ; Yan GQ; Li T; He M; Huang QR
    Eur J Pharmacol; 2015 May; 754():41-51. PubMed ID: 25687252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor gamma and cardiovascular diseases.
    Takano H; Komuro I
    Circ J; 2009 Feb; 73(2):214-20. PubMed ID: 19129679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smooth Muscle Peroxisome Proliferator-Activated Receptor γ Plays a Critical Role in Formation and Rupture of Cerebral Aneurysms in Mice In Vivo.
    Hasan DM; Starke RM; Gu H; Wilson K; Chu Y; Chalouhi N; Heistad DD; Faraci FM; Sigmund CD
    Hypertension; 2015 Jul; 66(1):211-20. PubMed ID: 25916724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-related differences in the effects of α and γ peroxisome proliferator-activated receptor subtype agonists on endothelial vasodilation in human microvessels.
    Angulo J; Vallejo S; El Assar M; García-Septiem J; Sánchez-Ferrer CF; Rodríguez-Mañas L
    Exp Gerontol; 2012 Sep; 47(9):734-40. PubMed ID: 22776133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin protects endothelial function in diet-induced obese mice by inhibition of endoplasmic reticulum stress through 5' adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor δ pathway.
    Cheang WS; Tian XY; Wong WT; Lau CW; Lee SS; Chen ZY; Yao X; Wang N; Huang Y
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):830-6. PubMed ID: 24482374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of peroxisome proliferator-activated receptor-γ in atherosclerosis: an update.
    Wang N; Yin R; Liu Y; Mao G; Xi F
    Circ J; 2011; 75(3):528-35. PubMed ID: 21325726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor-γ and the endothelium: implications in cardiovascular disease.
    Magri CJ; Gatt N; Xuereb RG; Fava S
    Expert Rev Cardiovasc Ther; 2011 Oct; 9(10):1279-94. PubMed ID: 21985541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Submaximal PPARγ activation and endothelial dysfunction: new perspectives for the management of cardiovascular disorders.
    Balakumar P; Kathuria S
    Br J Pharmacol; 2012 Aug; 166(7):1981-92. PubMed ID: 22404217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome Proliferator-Activated Receptor γ Regulates the V-Ets Avian Erythroblastosis Virus E26 Oncogene Homolog 1/microRNA-27a Axis to Reduce Endothelin-1 and Endothelial Dysfunction in the Sickle Cell Mouse Lung.
    Kang BY; Park K; Kleinhenz JM; Murphy TC; Sutliff RL; Archer D; Hart CM
    Am J Respir Cell Mol Biol; 2017 Jan; 56(1):131-144. PubMed ID: 27612006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.